ChemicalBook
English   Japanese   Germany   Korea

cyclohexyl 4-(1,8-dibromo-16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)benzoate

, 497945-57-0, 结构式
CAS号:
497945-57-0
英文名:
cyclohexyl 4-(1,8-dibromo-16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)benzoate
英文别名:
Benzoic acid, 4-(4,9-dibromo-1,3,3a,4,9,9a-hexahydro-1,3-dioxo-4,9[1',2']-benzeno-2H-benz[f]isoindol-2-yl)-, cyclohexyl ester;cyclohexyl 4-(1,8-dibromo-16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)benzoate
中文名:
中文别名:
CBNumber:
CB61884081
分子式:
C31H25Br2NO4
分子量:
635.3425
MOL File:
497945-57-0.mol

cyclohexyl 4-(1,8-dibromo-16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)benzoate化学性质

沸点:
744.4±60.0 °C(Predicted)
密度:
1.68±0.1 g/cm3(Predicted)
酸度系数(pKa):
-5.63±0.60(Predicted)
安全信息

cyclohexyl 4-(1,8-dibromo-16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)benzoate性质、用途与生产工艺

cyclohexyl 4-(1,8-dibromo-16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)benzoate 上下游产品信息

上游原料

下游产品

cyclohexyl 4-(1,8-dibromo-16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)benzoate 生产厂家

全球有 1家供应商   cyclohexyl 4-(1,8-dibromo-16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)benzoate国内生产厂家
供应商联系电话电子邮件国家产品数优势度
SPECS info@specs.net 荷兰 6835 70
 

497945-57-0, cyclohexyl 4-(1,8-dibromo-16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)benzoate 相关搜索:

  • C31H25Br2NO4
  • 497945-57-0
  • Benzoic acid, 4-(4,9-dibromo-1,3,3a,4,9,9a-hexahydro-1,3-dioxo-4,9[1',2']-benzeno-2H-benz[f]isoindol-2-yl)-, cyclohexyl ester
  • cyclohexyl 4-(1,8-dibromo-16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)benzoate
Copyright 2016 © ChemicalBook. All rights reserved